Publication | Open Access
Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer
30
Citations
25
References
2024
Year
These findings suggest that a pathomics signature could help identify patients most likely to benefit from chemotherapy in stage III colon cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1